BMS-196085: A potent and selective full agonist of the human β3 adrenergic receptor
- 5 October 2001
- journal article
- research article
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 11 (23) , 3041-3044
- https://doi.org/10.1016/s0960-894x(01)00629-1
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Beta 3 agonists. Part 1: evolution from inception to BMS-194449Bioorganic & Medicinal Chemistry Letters, 2001
- Development of ?3-adrenoceptor agonists as antiobesity and antidiabetes drugs in humans: Current status and future prospectsDrug Development Research, 2000
- Medicinal strategies in the treatment of obesityNature, 2000
- Pharmacological Treatment of Obesity: Therapeutic StrategiesJournal of Medicinal Chemistry, 1999
- β3 Adrenergic Receptor Agonists for the Treatment of ObesityPublished by Elsevier ,1998
- β1‐ and β2‐adrenoceptor antagonist activities of ICI‐215001, a putative β3‐adrenoceptor agonistBritish Journal of Pharmacology, 1994
- Lead Tetraacetate Cleavage of Chiral Phenylglycinol Derived Secondary Amines Without RacemizationSynthetic Communications, 1993
- Synthesis of chiral .alpha.-alkyl phenethylamines via organometallic addition to chiral 2-aryl-1,3-oxazolidinesThe Journal of Organic Chemistry, 1991
- Preparation of primary amines and 2-azetidinones via N-(trimethylsilyl)iminesThe Journal of Organic Chemistry, 1983
- FACILE SYNTHESIS OF BENZYL KETONES BY THE REDUCTIVE COUPLING OF BENZYL BROMIDE AND ACYL CHLORIDES IN THE PRESENCE OF A PALLADIUM CATALYST AND ZINC POWDERChemistry Letters, 1981